United States: Gunfights At The Deeply Divided Federal Circuit OK Corral Over "Ready For Patenting," Useful For The Intended Purpose, And Experimental Use

Decision: Barry v. Medtronic, --F.3d__, 2019 WL 302886 (Fed. Cir. Jan. 24, 2019) (Judges TARANTO, Prost, and Moore; dissenting opinion in part filed by Judge Prost)

Background: Dr. Barry sued Medtronic on two patents, which contained method and system claims. A jury, finding Medtronic infringed, rejected both public use and on-sale bar arguments. In a divided Federal Circuit opinion, Dr. Barry prevailed (infringement, no on-sale bar, no public use bar, experimental use), but Judge Prost dissented that (1) the invention was ready for patenting more than one year before the critical date and (2) that the patentee had not established an experimental use negation of on-sale and public use.

Dr. Barry worked on his ideas for a spine correction device and related surgical methods in 2003. He performed three surgeries using his inventions on Aug. 4, Aug. 5, and Oct. 14, 2003, and charged for those surgeries without mentioning to the patients that the device and methods were experimental.

Those three patients had follow-up appointments between Aug. 2003 and Jan. 2004. After the January 2004, follow up, Dr. Barry submitted a Feb. 1, 2004, abstract describing his methods for a presentation in July 2004. He also filed a U.S. patent application on December 30, 2004, ultimately resulting in U.S. Patent 7,679,358 (the '358 patent), i.e., the principal patent litigated before the Federal Circuit. The critical date for 35 U.S.C. §102(b) therefore was deemed to be December 30, 2003.

Issue: Was Dr. Barry's invention in public use or on sale before December 30, 2003? If so, were the public use and sale bars negated by experimental use?

Outcome: Affirmed (2-1).

The Federal Circuit majority found that (1) the invention was not ready for patenting prior to the critical date, eliminating both the public use and on sale bars, and (2) that up to the critical date, there was only experimental use, not public use or sale. "[E]experimental use negates invalidity under the public use bar."

The majority, concluding that "the timing of knowledge that the invention will 'work for its intended purpose' is important to both experimental use and readiness for patenting," emphasized that the "'intended purpose' need not be stated in claim limitations that define the claim scope." The majority found that substantial evidence supported the conclusion that Dr. Barry did not know his invention would work for its intended purpose until January 2004, after completion and follow up of the August and October 2003 surgeries.

The majority also rejected Medtronic's argument that the invention was accessible to the public and commercially exploited and thus was in public use prior to the critical date. The court stated that Dr. Barry was the only one who performed the claimed method and that he never relinquished control of his method invention and whatever disclosure there was during the surgeries was protected by an implied duty of confidentiality in the operating room. Furthermore, according to the majority, the evidence supported the conclusion that the surgeries were legitimate experimental use, even if Dr. Barry was compensated for them at his normal rate.

"The experimental-use inquiry asks whether the inventor's conduct would lead the ''public' to reasonably believe the invention was in the public domain[.]'" The majority concluded that the answer in this case was "no."

The Court also rejected Medtronic's argument that experimental use did not apply because the patients were not informed that Dr. Barry was experimenting during their surgeries.

We have not applied the inform-customer principle in a context, like the present, involving a method kept within the inventor's control. The underlying logic of the principle does not justify its extension here: explaining to patients (or their parents or insurers) that the procedure was experimental was not vital to keeping it from the public domain.

at *13.

Judge Prost issued a strong dissent, spanning over twenty pages.  She concluded that Dr. Barry's successful completion of three surgeries before the critical date was prima facie "on sale" or "public use." Pfaff's commercial sale and ready for patenting prongs were both satisfied. "[R]eadiness for patenting is broader than reduction to practice and is meant to answer whether the inventor could have obtained a patent on his or her invention." She concluded that by the end of the follow up of the second surgery, more than one year before the critical date, the claimed methods were reduced to practice as a matter of law.

In emphasizing that "ready for patenting" is broader than reduction to practice, Judge Prost focused on when Dr. Barry could have obtained a patent, concluding that it was at the end of the follow up of the second surgery. She reasoned that by then, Dr. Barry possessed enough to satisfy written description, enablement, and utility, particularly in view of the broad statement of intended use in the preamble of the claims. 

The gravamen of Judge Prost's dissent is that the majority asked more of the intended purpose "than what the claims and specification define it to be." 

Finally, Judge Prost was underwhelmed by the experimental use negation, finding that most of it was based on Dr.  Barry's evidence that was "just his own after-the-fact testimony."

"Dr. Barry's evidence of experimental purpose was insufficient as a matter of law to negate a bar" because it was largely based on his own litigation testimony. There was little objective evidence to support the assertion of experimental use.

Prosecution Takeaways:

Showing experimental use to negate public use or on sale argument is a very fact-intensive inquiry.  The more inventors can do to record the development path of their invention as it is happening and articulate the "intended purpose" of the invention with specificity in the claims and/or specification, the stronger a theory of experimental use may be, as well as the stronger a theory of not ready for patenting may be.

This case also serves as a cautionary tale to patent applicants to be mindful of statutory bar dates and to try and closely coordinate commercial and patenting efforts. The patents in Barry were pre-AIA patents. This caution is even stronger for AIA first inventor-to-file patents.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions